XSHE
300677
Market cap4.57bUSD
Oct 09, Last price
49.00CNY
1D
4.90%
1Q
6.52%
IPO
203.41%
Name
Intco Medical Technology Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Intco Medical Technology Co., Ltd. is a company dedicated to the development, manufacturing, and worldwide distribution of both single-use medical products and durable medical equipment, serving markets within China and internationally. Their extensive product portfolio includes a variety of personal protective equipment like gloves, face masks, and shields, as well as essential clinical supplies such as ECG electrodes, medical apparel (e.g., isolation gowns), and hand hygiene solutions in both gel and spray forms. The company also produces specialized surgical components, including grounding pads, electrosurgical pencils, ESU cables, tip cleaners, and TENS electrodes. Beyond disposables, Intco Medical supplies a range of robust medical devices, notably mobility aids such as wheelchairs and scooters, along with other general medical apparatus. Their offerings further extend to temperature therapy items, emergency treatment provisions, products for maternal and infant care, and various home healthcare solutions. Established in 2009 and headquartered in Zibo, China, the company underwent a formal corporate name update in January 2020, maintaining its designation as Intco Medical Technology Co., Ltd.
Key people
Jie Feng
Chief Financial Officer, Secretary of the Board · since 2024
Haisheng Yu
Deputy General Manager, Director · since 2018
Qiong Chen
General Manager, Director · since 2015
Fangyi Liu
Chairman of the Board · since 2009
Jing Sun
Director · since 2015
Jianjun Jia
Independent Director · since 2025
Xiaohui Wu
Independent Director · since 2022
Independent Director · since 2022
Headquarters & legal address
NO. 18 QINGTIAN ROAD
QILU CHEMICAL INDUSTRY PARK, LINZI DISTRICT
ZIBO, SD
CN
QILU CHEMICAL INDUSTRY PARK, LINZI DISTRICT
ZIBO, SD
CN
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||